Gilead’s New $250M Drug R&D Pact Adds Contenders in the Hunt for Hot Inflammation Target
Gilead Sciences’ inflammation drug prospects have come via deals, and the latest one brings drug candidates for an elusive target ...
Monday, January 13, 2025
Tag: Gileads